Brevan Howard Capital Management LP Beam Therapeutics Inc. Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 49,811 shares of BEAM stock, worth $1.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
49,811Holding current value
$1.1 Million% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding BEAM
# of Institutions
249Shares Held
95MCall Options Held
888KPut Options Held
549K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11MShares$243 Million1.88% of portfolio
-
Farallon Capital Management LLC San Francisco, CA10.1MShares$222 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.25MShares$204 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$168 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.4.83MShares$106 Million1.27% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.55B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...